Literature DB >> 10768968

Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas.

T J Bodetti1, P Timms.   

Abstract

Chlamydia pneumoniae is a common respiratory pathogen of humans which, in addition to causing disease at the respiratory site, has recently been linked to disease at other body sites. If C. pneumoniae does contribute to disease at nonrespiratory sites, then it must have a mechanism by which it reaches these sites. We analyzed the peripheral blood mononuclear cell (PBMC) fractions from 60 healthy human blood donors for the presence of C. pneumoniae DNA (by ompA PCR) and chlamydial antigens (by genus- and species-specific monoclonal antibody staining). Ten of the sixty (16. 7%) blood donors were C. pneumoniae positive by PCR, and all 10 of these PCR-positive individuals' samples demonstrated specific staining with anti-C. pneumoniae monoclonal antibodies. The only other host naturally infected with C. pneumoniae is the koala, in which the bacterium also causes respiratory infections. We demonstrated the presence of C. pneumoniae DNA and antigens in the PBMC fractions of 30% of 20 koalas tested. Our finding of C. pneumoniae-infected PBMCs in koalas as well as humans suggests that the ability to infect PBMCs and to disseminate from the respiratory site is not restricted to the human biovar of C. pneumoniae but is a general characteristic of this chlamydial species.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768968      PMCID: PMC97483          DOI: 10.1128/IAI.68.5.2744-2747.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Epizootiology of Chlamydia infections in two free-range koala populations.

Authors:  M Jackson; N White; P Giffard; P Timms
Journal:  Vet Microbiol       Date:  1999-03-19       Impact factor: 3.293

Review 2.  Infections caused by Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

3.  High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

Authors:  J Boman; S Söderberg; J Forsberg; L S Birgander; A Allard; K Persson; E Jidell; U Kumlin; P Juto; A Waldenström; G Wadell
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

4.  Chlamydia pneumoniae in vascular tissues from heart-transplant donors.

Authors:  D Taylor-Robinson; G Ong; B J Thomas; M L Rose; M H Yacoub
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

5.  Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse.

Authors:  T C Moazed; C C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

6.  Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease.

Authors:  Y K Wong; K D Dawkins; M E Ward
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

7.  Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection.

Authors:  F Blasi; J Boman; G Esposito; G Melissano; R Chiesa; R Cosentini; P Tarsia; Y Tshomba; M Betti; M Alessi; N Morelli; L Allegra
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

8.  Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease.

Authors:  M Maass; C Bartels; P M Engel; U Mamat; H H Sievers
Journal:  J Am Coll Cardiol       Date:  1998-03-15       Impact factor: 24.094

9.  Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.

Authors:  M B Aldous; J T Grayston; S P Wang; H M Foy
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.

Authors:  C A Gaydos; J T Summersgill; N N Sahney; J A Ramirez; T C Quinn
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  17 in total

1.  Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography.

Authors:  M Smieja; S Chong; M Natarajan; A Petrich; L Rainen; J B Mahony
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion.

Authors:  Hideaki Ikejima; Herman Friedman; German F Leparc; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

6.  Detection and Differentiation of Two Koala Gammaherpesviruses by Use of High-Resolution Melt (HRM) Analysis Reveals Differences in Viral Prevalence and Clinical Associations in a Large Study of Free-Ranging Koalas.

Authors:  P K Vaz; A R Legione; C A Hartley; J M Devlin
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

7.  Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures.

Authors:  Melanie Cochrane; Andreas Pospischil; Philip Walker; Harry Gibbs; Peter Timms
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

8.  Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.

Authors:  Corinna Hermann; Kathrin Graf; Annemarie Groh; Eberhard Straube; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

10.  Novel Parachlamydia acanthamoebae quantification method based on coculture with amoebae.

Authors:  Junji Matsuo; Yasuhiro Hayashi; Shinji Nakamura; Marie Sato; Yoshihiko Mizutani; Masahiro Asaka; Hiroyuki Yamaguchi
Journal:  Appl Environ Microbiol       Date:  2008-08-29       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.